April 23, 2019

FDA considering additional regulatory actions to reduce duodenoscope risks

By: Judy Mathias
Share

Editor’s Note

The Food & Drug Administration on April 16 announced it is considering additional regulatory actions, including consulting with federal health experts for guidance, to reduce the risks of contamination and infections associated with duodenoscopes.

The FDA is also working with manufacturers of disposable duodenoscopes that would make reprocessing unnecessary and on new device designs that may decrease contamination risks.

Read More >>

Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

OR Manager Jobs
Upcoming Webinars
Live chat by BoldChat